Longevity Health (NASDAQ:XAGE) Shares Up 11.7% – Here’s What Happened

Longevity Health Holdings, Inc. (NASDAQ:XAGE) shot up 11.7% during trading on Tuesday . The company traded as high as $0.6499 and last traded at $0.6499. 809 shares traded hands during mid-day trading, a decline of 100% from the average session volume of 762,144 shares. The stock had previously closed at $0.5820.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen upgraded shares of Longevity Health from a “sell” rating to a “hold” rating in a report on Saturday, August 9th.

Longevity Health Trading Up 11.7%

The company has a market cap of $1.16 million, a price-to-earnings ratio of -0.09 and a beta of 0.34. The firm’s 50 day moving average price is $0.97.

Longevity Health (NASDAQ:XAGE) last posted its earnings results on Thursday, August 14th. The company reported ($1.56) EPS for the quarter. The company had revenue of $0.50 million during the quarter.

Hedge Funds Weigh In On Longevity Health

An institutional investor recently bought a new position in Longevity Health stock. Bank of Montreal Can purchased a new position in shares of Longevity Health Holdings, Inc. (NASDAQ:XAGE) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 12,000 shares of the company’s stock, valued at approximately $30,000. Bank of Montreal Can owned approximately 1.20% of Longevity Health as of its most recent filing with the Securities and Exchange Commission (SEC). Institutional investors own 24.22% of the company’s stock.

About Longevity Health

Carmell Therapeutics Corporation focuses on the development of plasma-based bioactive material (PBM) to stimulate tissue repair or growth after injury, disease, and aging. Its lead product candidate is CT-101 bone healing accelerant for tibia fracture healing, foot/ankle fusion, spinal fusion, dental bone graft substitute, and bone void filler; and tissue healing accelerant for androgenetic alopecia and chronic wound healing.